Associated Papers
Plasminogen activator inhibitor-1: a potential etiological role in livedoid vasculopathy.
Gao Y et al.
International Wound Journal, 2020
Contribution of inherited thrombophilia to recurrent miscarriage in the Polish population.
Wolski H et al.
Ginekologia Polska, 2017
Pharmacogenetic considerations for acute lymphoblastic leukemia therapies.
Dulucq S et al.
Expert Opinion on Drug Metabolism & Toxicology, 2014
Multifactor dimensionality reduction analysis of MTHFR, PAI-1, ACE, PON1, and eNOS gene polymorphisms in patients with early onset coronary artery disease.
Agirbasli M et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology, 2011
Genetic cardiovascular risk factors and age-related macular degeneration.
Haas P et al.
Acta Ophthalmologica, 2011
Pharmacogenetics in cardiovascular antithrombotic therapy.
Marín F et al.
Journal of the American College of Cardiology, 2009
[Inherited thrombophilia as the reason of recurrent miscarriges in the first trimester of pregnancy].
Kurzawińska G et al.
Ginekologia Polska, 2009
[Inherited thrombophilia in women with recurrent miscarriages and pregnancy loss in anamnesis--own experience].
Seremak-Mrozikiewicz A et al.
Ginekologia Polska, 2008
Type I plasminogen activator inhibitor 4G allele frequency is associated with chronic venous insufficiency.
Katrancioglu N et al.
The Journal of International Medical Research, 0
Deep vein thrombosis after bunionectomy: a case report of two genetic mutations.
Peterson KS et al.
The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons, 0